Clinical Trial

The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a observational, multicenter study, monitoring the circulating tumor DNA (ctDNA) in people who is at risk of cancers，assessing the sensitivity and specificity of ctDNA detection in early screening of pan-carcinoma.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-05-22; most recent amendment 2025-08-27.
Status change: Recruiting → Active, Not Recruiting 2024-07-16
Status change: Active, Not Recruiting → Recruiting 2023-05-25
Status change: Recruiting → Active, Not Recruiting 2022-03-15
Trial Details
NCT Number NCT04405557
Lead Sponsor Geneplus-Beijing Co. Ltd.
Collaborators: Chinese PLA General Hospital
Conditions Early Detection of Cancer
Enrollment 757 participants
Start Date 2019-11-12
Primary Completion 2022-01-16 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-04